Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Few pathogens have historically been subjected to as intense scientific and clinical scrutiny as SARS-CoV-2. The genetic, immunological, and environmental factors influencing disease severity and post-infection clinical outcomes, known as correlates of immunity, remain largely undefined. Clinical ou...
Saved in:
Main Authors: | Yannick Galipeau, Curtis Cooper, Marc-André Langlois |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1509289/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidative Stress and Its Association with COVID-19: A Narrative Review
by: Hardi Rafat Baqi, et al.
Published: (2020-06-01) -
Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic
by: Temitope Isaac Adelusi, et al.
Published: (2025-01-01) -
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
by: Hiam Naiditch, et al.
Published: (2025-02-01) -
Characteristics and long-term health outcomes of the first domestic COVID-19 outbreak cases in Da Nang, Vietnam: a longitudinal cohort study
by: Miyuki Tsuruoka, et al.
Published: (2025-01-01) -
Predictors of specialist care referrals (SCR) following emergency department review or hospital admission in adults with previous acute COVID-19: a prospective UK cohort study
by: Anita Saigal, et al.
Published: (2025-01-01)